首页 > 最新文献

Microbiology Research最新文献

英文 中文
Microbiome of Clothing Items Worn for a Single Day in a Non-Healthcare Setting 在非医疗环境中穿一天衣服的微生物群
IF 1.5 Q3 MICROBIOLOGY Pub Date : 2023-07-26 DOI: 10.3390/microbiolres14030065
K. Whitehead, Jake Eppinger, V. Srinivasan, M. K. Ijaz, R. Nims, J. McKinney
When worn, clothing acquires a microbiome of bacteria and fungi derived from the wearer’s skin and from the environment. The types of bacteria and fungi that may be recovered from clothing in healthcare settings have been well characterized, but less is known regarding the microbiome of clothing worn in non-healthcare settings and the possible roles that such clothing may play in microbial exchange. Culture-based methods and culture-independent genomic sequencing were used to enumerate and identify bacteria and fungi recovered from T-shirts, baby onesies, socks, and underwear worn for a single day after having been purchased new, washed, and dried. The highest bacterial loads were recovered from socks, underwear, and onesies (>106 colony-forming units [cfu]/sample) and the highest fungal loads were obtained from socks and underwear (>5 × 102 cfu/sample). The sequencing method identified opportunistic pathogens present in the samples, including members of genus Staphylococcus and Corynebacterium, as well as anaerobic members of the family Clostridiales. The opportunistic fungal pathogen Candida parapsilosis was identified in a high proportion of worn clothing samples. These results suggest that clothing may represent a pathogen reservoir and a vector for microbial exchange between household occupants or the community outside of the home.
当穿着时,衣服从穿着者的皮肤和环境中获得细菌和真菌的微生物群。在医疗保健环境中,可以从衣服中回收的细菌和真菌的类型已经有了很好的特征,但关于在非医疗保健环境中穿的衣服的微生物组以及这种衣服在微生物交换中可能发挥的作用,人们知之甚少。使用基于培养的方法和与培养无关的基因组测序来枚举和鉴定从新购买、洗涤和干燥后穿一天的t恤、婴儿连体衣、袜子和内衣中回收的细菌和真菌。袜子、内衣和连体衣的细菌负荷最高(>106菌落形成单位[cfu]/份),袜子和内衣的真菌负荷最高(>5 × 102 cfu/份)。测序方法鉴定了样品中存在的机会致病菌,包括葡萄球菌属和棒状杆菌属的成员,以及梭菌属的厌氧成员。机会性真菌病原体假丝酵母在高比例的旧衣服样品中被鉴定出来。这些结果表明,衣物可能是病原体储存库和家庭居住者或家庭外社区之间微生物交换的媒介。
{"title":"Microbiome of Clothing Items Worn for a Single Day in a Non-Healthcare Setting","authors":"K. Whitehead, Jake Eppinger, V. Srinivasan, M. K. Ijaz, R. Nims, J. McKinney","doi":"10.3390/microbiolres14030065","DOIUrl":"https://doi.org/10.3390/microbiolres14030065","url":null,"abstract":"When worn, clothing acquires a microbiome of bacteria and fungi derived from the wearer’s skin and from the environment. The types of bacteria and fungi that may be recovered from clothing in healthcare settings have been well characterized, but less is known regarding the microbiome of clothing worn in non-healthcare settings and the possible roles that such clothing may play in microbial exchange. Culture-based methods and culture-independent genomic sequencing were used to enumerate and identify bacteria and fungi recovered from T-shirts, baby onesies, socks, and underwear worn for a single day after having been purchased new, washed, and dried. The highest bacterial loads were recovered from socks, underwear, and onesies (>106 colony-forming units [cfu]/sample) and the highest fungal loads were obtained from socks and underwear (>5 × 102 cfu/sample). The sequencing method identified opportunistic pathogens present in the samples, including members of genus Staphylococcus and Corynebacterium, as well as anaerobic members of the family Clostridiales. The opportunistic fungal pathogen Candida parapsilosis was identified in a high proportion of worn clothing samples. These results suggest that clothing may represent a pathogen reservoir and a vector for microbial exchange between household occupants or the community outside of the home.","PeriodicalId":43788,"journal":{"name":"Microbiology Research","volume":"10 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84161880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microorganisms and Climate Change: A Not so Invisible Effect 微生物与气候变化:一个并非无形的影响
IF 1.5 Q3 MICROBIOLOGY Pub Date : 2023-07-25 DOI: 10.3390/microbiolres14030064
A. Ibáñez, Sonia Garrido-Chamorro, C. Barreiro
The effect of climate change on flora and fauna has been widely discussed for years. However, its consequences on microorganisms are generally poorly considered. The main effect of climate change on microbiota is related to biodiversity changes in different regions of the planet, mainly due to variations in temperature. These alterations are resulting in a worldwide (re)distribution of pathogens, which was not considered a few years ago. They mainly affect different food chain sectors (such as agriculture, livestock and fishing), as well as human health. Hence, the spread of numerous animal and plant pathogens has been observed in recent years from south to north (especially in America, Europe and Asia), leading to the spread of numerous plant and animal diseases, which results in economic and ecological losses. In addition, global warming that accompanies climate change could also be related to emerging antibiotic resistance. However, the mitigation of climate change goes hand in hand with microorganisms, which can help us through different natural and industrial processes. Thus, this manuscript presents the direct and indirect effects of climate change on microorganisms described up to date and how they act on this worldwide phenomenon.
气候变化对动植物的影响已被广泛讨论多年。然而,它对微生物的影响通常没有得到充分考虑。气候变化对微生物群的主要影响与地球不同区域的生物多样性变化有关,主要是由于温度的变化。这些变化导致病原体在世界范围内(重新)分布,这在几年前是没有被考虑到的。它们主要影响不同的食物链部门(如农业、畜牧业和渔业)以及人类健康。因此,近年来观察到许多动植物病原体从南向北传播(特别是在美洲、欧洲和亚洲),导致许多动植物疾病传播,造成经济和生态损失。此外,伴随气候变化的全球变暖也可能与抗生素耐药性的出现有关。然而,减缓气候变化与微生物密切相关,微生物可以通过不同的自然和工业过程帮助我们。因此,本文介绍了气候变化对微生物的直接和间接影响,以及它们如何作用于这一全球现象。
{"title":"Microorganisms and Climate Change: A Not so Invisible Effect","authors":"A. Ibáñez, Sonia Garrido-Chamorro, C. Barreiro","doi":"10.3390/microbiolres14030064","DOIUrl":"https://doi.org/10.3390/microbiolres14030064","url":null,"abstract":"The effect of climate change on flora and fauna has been widely discussed for years. However, its consequences on microorganisms are generally poorly considered. The main effect of climate change on microbiota is related to biodiversity changes in different regions of the planet, mainly due to variations in temperature. These alterations are resulting in a worldwide (re)distribution of pathogens, which was not considered a few years ago. They mainly affect different food chain sectors (such as agriculture, livestock and fishing), as well as human health. Hence, the spread of numerous animal and plant pathogens has been observed in recent years from south to north (especially in America, Europe and Asia), leading to the spread of numerous plant and animal diseases, which results in economic and ecological losses. In addition, global warming that accompanies climate change could also be related to emerging antibiotic resistance. However, the mitigation of climate change goes hand in hand with microorganisms, which can help us through different natural and industrial processes. Thus, this manuscript presents the direct and indirect effects of climate change on microorganisms described up to date and how they act on this worldwide phenomenon.","PeriodicalId":43788,"journal":{"name":"Microbiology Research","volume":"41 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90342006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Molecular Epidemiology of Enterovirus in a Birth Cohort in Nepal 尼泊尔出生队列肠病毒的分子流行病学研究
IF 1.5 Q3 MICROBIOLOGY Pub Date : 2023-07-20 DOI: 10.3390/microbiolres14030063
S. Shrestha, J. Shrestha, T. Strand, S. Numanovic, A. Andreassen, J. Dembinski, R. Vikse, S. Dudman
Acute gastroenteritis (AGE) has a major impact on morbidity and mortality worldwide. The viral aetiology of diarrhoeal diseases may remain unknown due to limited diagnostic facilities. Non-polio enteroviruses (NPEVs) are the third most frequent pathogen detected in stool specimens from AGE cases, yet their potential role in AGE is uncertain. In Nepal, limited data are available on NPEVs, due to both the lack of an adequate surveillance program and the availability of tests. The global polio eradication initiative effort of the WHO has eradicated the incidence of poliomyelitis and acute flaccid paralysis (AFP) from many parts of the world, including Nepal. However, cases of AFP associated with NPEVs have been reported in different countries, including the neighbouring India. This study aims to investigate the diarrhoeal stool samples from a birth cohort until the age of 36 months for NPEVs and the genotype diversity of NPEV in community children with diarrhoea. A total of 280 longitudinal diarrhoeal stool samples that were negative for other enteric pathogens were tested using RT-PCRs. NPEVs was detected in 97 stool specimens (34.6%) and were significantly more frequent in infants up to one year of age. This study identified 17 various NPEV types, with the dominating species being Enterovirus B (EV-B). Ten different types of echoviruses were recorded in this study, with the two rare NPEVs B74 and A120. Based on prevalence, seasonality, and diversity, further studies are warranted to investigate the role of enterovirus in diarrhoeal disease.
急性胃肠炎(AGE)在世界范围内对发病率和死亡率有重大影响。由于诊断设施有限,腹泻病的病毒病因可能仍然未知。非脊髓灰质炎肠道病毒(npev)是AGE病例粪便标本中检测到的第三大常见病原体,但其在AGE中的潜在作用尚不确定。在尼泊尔,由于缺乏适当的监测规划和可获得的检测,关于非机动车的数据有限。世界卫生组织的全球根除脊髓灰质炎行动努力已经在世界许多地方,包括尼泊尔,消除了脊髓灰质炎和急性弛缓性麻痹的发病率。然而,AFP与npev相关的病例已在不同国家报告,包括邻国印度。本研究旨在调查来自出生队列的腹泻粪便样本,直到36个月的NPEV和社区腹泻儿童NPEV的基因型多样性。使用rt - pcr检测了280份其他肠道病原体呈阴性的纵向腹泻粪便样本。在97份粪便标本中检测到npev(34.6%),并且在一岁以下的婴儿中更为常见。本研究确定了17种不同的NPEV类型,主要种是肠病毒B (EV-B)。本研究记录了10种不同类型的埃可病毒,其中包括两种罕见的npev B74和A120。基于患病率、季节性和多样性,有必要进一步研究肠道病毒在腹泻病中的作用。
{"title":"The Molecular Epidemiology of Enterovirus in a Birth Cohort in Nepal","authors":"S. Shrestha, J. Shrestha, T. Strand, S. Numanovic, A. Andreassen, J. Dembinski, R. Vikse, S. Dudman","doi":"10.3390/microbiolres14030063","DOIUrl":"https://doi.org/10.3390/microbiolres14030063","url":null,"abstract":"Acute gastroenteritis (AGE) has a major impact on morbidity and mortality worldwide. The viral aetiology of diarrhoeal diseases may remain unknown due to limited diagnostic facilities. Non-polio enteroviruses (NPEVs) are the third most frequent pathogen detected in stool specimens from AGE cases, yet their potential role in AGE is uncertain. In Nepal, limited data are available on NPEVs, due to both the lack of an adequate surveillance program and the availability of tests. The global polio eradication initiative effort of the WHO has eradicated the incidence of poliomyelitis and acute flaccid paralysis (AFP) from many parts of the world, including Nepal. However, cases of AFP associated with NPEVs have been reported in different countries, including the neighbouring India. This study aims to investigate the diarrhoeal stool samples from a birth cohort until the age of 36 months for NPEVs and the genotype diversity of NPEV in community children with diarrhoea. A total of 280 longitudinal diarrhoeal stool samples that were negative for other enteric pathogens were tested using RT-PCRs. NPEVs was detected in 97 stool specimens (34.6%) and were significantly more frequent in infants up to one year of age. This study identified 17 various NPEV types, with the dominating species being Enterovirus B (EV-B). Ten different types of echoviruses were recorded in this study, with the two rare NPEVs B74 and A120. Based on prevalence, seasonality, and diversity, further studies are warranted to investigate the role of enterovirus in diarrhoeal disease.","PeriodicalId":43788,"journal":{"name":"Microbiology Research","volume":"4 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89886143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biocontrol Efficiency of Rhizospheric Bacillus against the Plant Pathogen Fusarium oxysporum: A Promising Approach for Sustainable Agriculture 根际芽孢杆菌对植物尖孢镰刀菌的生物防治效果:可持续农业的一条有前途的途径
IF 1.5 Q3 MICROBIOLOGY Pub Date : 2023-07-13 DOI: 10.3390/microbiolres14030062
Sarah Boulahouat, H. Cherif-Silini, A. Silini, A. C. Bouket, L. Luptakova, Faizah N. Alenezi, L. Belbahri
Among plant disease management strategies, biological control is a sustainable alternative to the use of chemicals for the control of vascular wilt caused by Fusarium oxysporum. Fusarium wilt is the most devastating disease affecting a wide variety of plants. Bacillus species are the most widely used biological control candidates for the control of these fungal diseases. This review describes the pathogenicity of F. oxysporum, its virulence mechanisms, and host plant–pathogen interactions. The control means deployed by Bacillus species inhibit or kill these phytopathogens. Bacillus spp. produce a wide range of secondary metabolites, including volatile and non-volatile organic compounds. Biocontrol potential is achieved through direct antimicrobial activity, the induction of the host plant’s immune response (Induced Systemic Resistance), and competition for nutrients and space. In addition, parameters governing the selection of effective biocontrol agents and their survival in plant microbial communities are discussed. The influence of the microbiota on the establishment and development of biocontrol agents can assess the potential of these treatments and facilitate the development of effective biopesticides during their field application.
在植物病害管理策略中,生物防治是替代化学药剂防治尖孢镰刀菌(Fusarium oxysporum)血管性枯萎病的一种可持续的方法。枯萎病是影响多种植物的最具破坏性的疾病。芽孢杆菌是控制这些真菌疾病最广泛使用的生物防治候选者。本文综述了尖孢镰刀菌的致病性、毒力机制以及寄主植物与病原菌的相互作用。芽孢杆菌采取的控制手段可以抑制或杀死这些植物病原体。芽孢杆菌产生多种次生代谢物,包括挥发性和非挥发性有机化合物。生物防治潜力是通过直接的抗菌活性、诱导寄主植物的免疫反应(诱导系统性抗性)以及对养分和空间的竞争来实现的。此外,还讨论了控制有效生物防治剂选择的参数及其在植物微生物群落中的存活。微生物群对生物防治剂的建立和开发的影响可以评估这些处理方法的潜力,并在其现场应用过程中促进有效生物农药的开发。
{"title":"Biocontrol Efficiency of Rhizospheric Bacillus against the Plant Pathogen Fusarium oxysporum: A Promising Approach for Sustainable Agriculture","authors":"Sarah Boulahouat, H. Cherif-Silini, A. Silini, A. C. Bouket, L. Luptakova, Faizah N. Alenezi, L. Belbahri","doi":"10.3390/microbiolres14030062","DOIUrl":"https://doi.org/10.3390/microbiolres14030062","url":null,"abstract":"Among plant disease management strategies, biological control is a sustainable alternative to the use of chemicals for the control of vascular wilt caused by Fusarium oxysporum. Fusarium wilt is the most devastating disease affecting a wide variety of plants. Bacillus species are the most widely used biological control candidates for the control of these fungal diseases. This review describes the pathogenicity of F. oxysporum, its virulence mechanisms, and host plant–pathogen interactions. The control means deployed by Bacillus species inhibit or kill these phytopathogens. Bacillus spp. produce a wide range of secondary metabolites, including volatile and non-volatile organic compounds. Biocontrol potential is achieved through direct antimicrobial activity, the induction of the host plant’s immune response (Induced Systemic Resistance), and competition for nutrients and space. In addition, parameters governing the selection of effective biocontrol agents and their survival in plant microbial communities are discussed. The influence of the microbiota on the establishment and development of biocontrol agents can assess the potential of these treatments and facilitate the development of effective biopesticides during their field application.","PeriodicalId":43788,"journal":{"name":"Microbiology Research","volume":"19 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72534822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evidence of Brucellosis in Hospitalized Patients of Selected Districts of Punjab, Pakistan 巴基斯坦旁遮普选定地区住院患者中布鲁氏菌病的证据
IF 1.5 Q3 MICROBIOLOGY Pub Date : 2023-07-10 DOI: 10.3390/microbiolres14030061
Amna Azam, Shahid Saleem Pall, I. Khan, Waqas Ahmad, T. Jamil, Aziz Ur Rehman, M. Imran, W. Shehzad, F. Melzer, M. F. Qamar, H. El-Adawy
Brucellosis is a bacterial zoonosis worldwide and a potential health risk in Pakistan due to socio-economic reasons and lack of awareness, veterinary health and modern dairy-processing facilities. The aim of this study was to determine the burden of brucellosis in hospitalized patients of selected districts of Punjab, Pakistan. To this end, a total of 280 serum samples were collected from suspected patients in districts Lahore, Okara and Khushab between 2016 and 2018. Anti-Brucella antibodies were detected in 89 (31.8%) sera by Rose Bengal plate test (RBPT), and Brucella abortus DNA was amplified by polymerase chain reaction (PCR) in 42 (15%) samples. In univariable analysis, the seroprevalence varied significantly (p < 0.05) between districts with Lahore indicating 41/101 (40.6%) Odds ratio (OR) = 53.98 (7.22–403.67; 95% CI), Okara 47/99 (47.5%) OR = 71.4 (9.55–533.65; 95% CI) and Khushab 1/80 (1.3%) as reference. Similarly, exposure to aborted materials and a history of blood transfusion did associate significantly (p < 0.05), posing OR = 2.91 (1.58–5.36; 95% CI) and OR = 4.48 (2.56–7.84; 95% CI) risk. However, consumption of raw milk and history of blood transfusion did associate significantly (p < 0.05) in multivariable analysis indicating OR = 1.91 (1.09–3.34; 95% CI) and OR = 4.92 (2.76–8.75; 95% CI), respectively. The association of history of blood transfusion as a brucellosis risk factor underscores the need to create brucellosis awareness programs both at public and institutional levels in the medical and veterinary fields, as well as facilities and capacity building to delve deeper into the epidemiology of brucellosis in the country. Particular attention should be paid to chronically infected patients. Therefore, laboratory modernization, standardization and validation of the diagnostic tests, and staff trainings are required. Finally, pasteurization of the milk is recommended before consumption.
布鲁氏菌病是一种世界性的细菌性人畜共患病,由于社会经济原因以及缺乏认识、兽医卫生和现代乳制品加工设施,在巴基斯坦是一种潜在的健康风险。本研究的目的是确定巴基斯坦旁遮普选定地区住院患者的布鲁氏菌病负担。为此,在2016年至2018年期间,从拉合尔、奥卡拉和库沙布地区的疑似患者中共收集了280份血清样本。玫瑰孟加拉平板法(RBPT)检测89份(31.8%)血清中检测到抗布鲁氏菌抗体,聚合酶链反应(PCR)扩增出42份(15%)流产布鲁氏菌DNA。单因素分析中,各地区血清阳性率差异有统计学意义(p < 0.05),其中拉合尔41/101(40.6%)优势比(OR) = 53.98 (7.22 ~ 403.67);95% CI), Okara 47/99 (47.5%) OR = 71.4 (9.55-533.65;95% CI)和Khushab 1/80(1.3%)作为参考。同样,流产材料暴露与输血史也显著相关(p < 0.05), OR = 2.91 (1.58-5.36;95% CI), OR = 4.48 (2.56-7.84;95% CI)风险。然而,在多变量分析中,原料奶的摄入量与输血史有显著相关(p < 0.05), OR = 1.91 (1.09-3.34;95% CI), OR = 4.92 (2.76-8.75;95% CI)。输血史与布鲁氏菌病风险因素的关联强调了在医疗和兽医领域的公共和机构层面建立布鲁氏菌病认识规划以及设施和能力建设的必要性,以便更深入地研究该国的布鲁氏菌病流行病学。应特别注意慢性感染患者。因此,需要对实验室进行现代化、标准化和验证诊断测试,并对工作人员进行培训。最后,建议在食用前对牛奶进行巴氏消毒。
{"title":"Evidence of Brucellosis in Hospitalized Patients of Selected Districts of Punjab, Pakistan","authors":"Amna Azam, Shahid Saleem Pall, I. Khan, Waqas Ahmad, T. Jamil, Aziz Ur Rehman, M. Imran, W. Shehzad, F. Melzer, M. F. Qamar, H. El-Adawy","doi":"10.3390/microbiolres14030061","DOIUrl":"https://doi.org/10.3390/microbiolres14030061","url":null,"abstract":"Brucellosis is a bacterial zoonosis worldwide and a potential health risk in Pakistan due to socio-economic reasons and lack of awareness, veterinary health and modern dairy-processing facilities. The aim of this study was to determine the burden of brucellosis in hospitalized patients of selected districts of Punjab, Pakistan. To this end, a total of 280 serum samples were collected from suspected patients in districts Lahore, Okara and Khushab between 2016 and 2018. Anti-Brucella antibodies were detected in 89 (31.8%) sera by Rose Bengal plate test (RBPT), and Brucella abortus DNA was amplified by polymerase chain reaction (PCR) in 42 (15%) samples. In univariable analysis, the seroprevalence varied significantly (p < 0.05) between districts with Lahore indicating 41/101 (40.6%) Odds ratio (OR) = 53.98 (7.22–403.67; 95% CI), Okara 47/99 (47.5%) OR = 71.4 (9.55–533.65; 95% CI) and Khushab 1/80 (1.3%) as reference. Similarly, exposure to aborted materials and a history of blood transfusion did associate significantly (p < 0.05), posing OR = 2.91 (1.58–5.36; 95% CI) and OR = 4.48 (2.56–7.84; 95% CI) risk. However, consumption of raw milk and history of blood transfusion did associate significantly (p < 0.05) in multivariable analysis indicating OR = 1.91 (1.09–3.34; 95% CI) and OR = 4.92 (2.76–8.75; 95% CI), respectively. The association of history of blood transfusion as a brucellosis risk factor underscores the need to create brucellosis awareness programs both at public and institutional levels in the medical and veterinary fields, as well as facilities and capacity building to delve deeper into the epidemiology of brucellosis in the country. Particular attention should be paid to chronically infected patients. Therefore, laboratory modernization, standardization and validation of the diagnostic tests, and staff trainings are required. Finally, pasteurization of the milk is recommended before consumption.","PeriodicalId":43788,"journal":{"name":"Microbiology Research","volume":"168 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87945903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Fructooligosaccharides (FOS) on the Immune Response of the Shrimp Penaeus vannamei and on the Reduction in Vibrio spp. and Pseudomonas spp. in Cultures of Post-Larvae 低聚果糖(FOS)对凡纳滨对虾(Penaeus vannamei)免疫反应及培养后弧菌和假单胞菌减少的影响
IF 1.5 Q3 MICROBIOLOGY Pub Date : 2023-07-08 DOI: 10.3390/microbiolres14030060
Yulaine Corrales Barrios, A. Roncarati, L. D. Martín Ríos, Maikelis Rodríguez González, Marbelys González Salotén, Yeidel López Zaldívar, A. Arenal
Penaeus spp. are the most cultivated type of shrimp because they have rapid growth and good adaptation to farming conditions. Due to diseases that result in high mortality and a decreased product quality, the cultivation of these shrimp globally, and in Cuba in particular, comes with the risk of significant financial losses. This study examined the effect of fructooligosaccharide (FOS, 1-kestose) on the growth and immune response of shrimp, as well as the multitude of Vibrio spp. and Pseudomonas spp. in Penaeus vannamei post-larvae under culture conditions. Fructooligosaccharide was applied in a completely randomized manner at a concentration of 0.4%, in both experimental groups with seventeen tanks each. In the results of this investigation, animals of greater weight (control 6.8 ± 0.2 mg; FOS 9.5 ± 0.3 mg; p < 0.001), length (control 1.1 ± 0.1 mm; FOS 1.3 ± 0.1 mm; p < 0.001), and survival (control 61.7% (95% CI of median 54.2–70.0); FOS 76.6% (95% CI of median 72.1–84.2); p < 0.001) were obtained when administered FOS relative to the control. An increase in the activity of proteases (p < 0.001), enzymes of the innate immune system such as phenoloxidase (p < 0.001), and lysozymes (p < 0.001) was observed, as well as an increase in the number of lectins (p < 0.001). Changes in the microbiota could be observed, with a reduction in Vibrio spp. and Pseudomonas spp. (control 2.4 × 103 ± 0.5 × 103; FOS 1.1 × 102 ± 0.3 × 102; p < 0.001). FOS improves the quality of the post-larvae of P. vannamei as reflected in the length, weight, and survival of the animals. Moreover, FOS stimulates the P. vannamei immune system through the enzymatic activities of phenoloxidase, lysozyme, and a number of lectins. The reduction in the population load of Vibrio spp. and Pseudomonas spp. might be a consequence of the improvement in the quality and immune system of P. vannamei.
对虾是养殖最多的虾类,因为它们生长迅速,对养殖条件适应良好。由于疾病导致高死亡率和产品质量下降,这些虾在全球,特别是在古巴的养殖面临重大经济损失的风险。本研究考察了低聚果糖(FOS, 1-酮糖)在培养条件下对凡纳滨对虾(Penaeus vannamei)幼虫生长和免疫反应的影响,以及对弧菌和假单胞菌数量的影响。低聚果糖以完全随机方式施用,浓度为0.4%,两组各17罐。在本研究结果中,体重较大的动物(对照组6.8±0.2 mg;FOS 9.5±0.3 mg;P < 0.001),长度(对照1.1±0.1 mm;FOS 1.3±0.1 mm;p < 0.001),生存率(对照组61.7% (95% CI为中位数54.2-70.0);FOS 76.6% (95% CI中位数72.1 ~ 84.2);p < 0.001)。观察到蛋白酶(p < 0.001)、先天免疫系统酶如酚氧化酶(p < 0.001)和溶菌酶(p < 0.001)活性的增加,以及凝集素数量的增加(p < 0.001)。观察到菌群的变化,弧菌和假单胞菌减少(对照组2.4 × 103±0.5 × 103;Fos 1.1 × 102±0.3 × 102;P < 0.001)。果寡糖提高了凡纳滨拟虫幼虫后期的质量,体现在动物的长度、重量和存活率上。此外,FOS通过酚氧化酶、溶菌酶和一些凝集素的酶活性刺激凡纳梅的免疫系统。弧菌和假单胞菌种群负荷的减少可能是由于南美假单胞菌质量和免疫系统的改善。
{"title":"Effects of Fructooligosaccharides (FOS) on the Immune Response of the Shrimp Penaeus vannamei and on the Reduction in Vibrio spp. and Pseudomonas spp. in Cultures of Post-Larvae","authors":"Yulaine Corrales Barrios, A. Roncarati, L. D. Martín Ríos, Maikelis Rodríguez González, Marbelys González Salotén, Yeidel López Zaldívar, A. Arenal","doi":"10.3390/microbiolres14030060","DOIUrl":"https://doi.org/10.3390/microbiolres14030060","url":null,"abstract":"Penaeus spp. are the most cultivated type of shrimp because they have rapid growth and good adaptation to farming conditions. Due to diseases that result in high mortality and a decreased product quality, the cultivation of these shrimp globally, and in Cuba in particular, comes with the risk of significant financial losses. This study examined the effect of fructooligosaccharide (FOS, 1-kestose) on the growth and immune response of shrimp, as well as the multitude of Vibrio spp. and Pseudomonas spp. in Penaeus vannamei post-larvae under culture conditions. Fructooligosaccharide was applied in a completely randomized manner at a concentration of 0.4%, in both experimental groups with seventeen tanks each. In the results of this investigation, animals of greater weight (control 6.8 ± 0.2 mg; FOS 9.5 ± 0.3 mg; p < 0.001), length (control 1.1 ± 0.1 mm; FOS 1.3 ± 0.1 mm; p < 0.001), and survival (control 61.7% (95% CI of median 54.2–70.0); FOS 76.6% (95% CI of median 72.1–84.2); p < 0.001) were obtained when administered FOS relative to the control. An increase in the activity of proteases (p < 0.001), enzymes of the innate immune system such as phenoloxidase (p < 0.001), and lysozymes (p < 0.001) was observed, as well as an increase in the number of lectins (p < 0.001). Changes in the microbiota could be observed, with a reduction in Vibrio spp. and Pseudomonas spp. (control 2.4 × 103 ± 0.5 × 103; FOS 1.1 × 102 ± 0.3 × 102; p < 0.001). FOS improves the quality of the post-larvae of P. vannamei as reflected in the length, weight, and survival of the animals. Moreover, FOS stimulates the P. vannamei immune system through the enzymatic activities of phenoloxidase, lysozyme, and a number of lectins. The reduction in the population load of Vibrio spp. and Pseudomonas spp. might be a consequence of the improvement in the quality and immune system of P. vannamei.","PeriodicalId":43788,"journal":{"name":"Microbiology Research","volume":"37 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75856902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3L, Three-Lactobacilli on Recovering of Microbiome and Immune-Damage by Cyclophosphamide Chemotherapy—A Pilot Experiment in Rats— 3 -乳酸菌对环磷酰胺化疗大鼠微生物组和免疫损伤的恢复作用
IF 1.5 Q3 MICROBIOLOGY Pub Date : 2023-07-06 DOI: 10.3390/microbiolres14030059
Shousong Yue, Zhenzhong Zhang, F. Bian, Yan Zhang, Gao Chen, Youfeng Zhu, Jun Li, J. Picimbon
We deal with various strains of Lactobacillus that can maintain the intestinal microbiome of rats treated with cyclophosphamide, an anticancer agent (chemotherapy). We use MiSeq and various types of statistical tests to prove that cyclophosphamide in rats alters the intestinal microbiome, favoring the growth of various fungi that are extremely harmful to intestinal metabolism. On the contrary, when Lactobacillus 3L is administered together with cyclophosphamide, we prove that the microbiome is preserved by having a much better intestinal metabolism.
我们处理各种乳酸菌菌株,可以维持大鼠的肠道微生物组治疗环磷酰胺,一种抗癌剂(化疗)。我们使用MiSeq和各种类型的统计检验证明,环磷酰胺在大鼠体内改变了肠道微生物组,有利于各种真菌的生长,而这些真菌对肠道代谢极为有害。相反,当乳酸菌3L与环磷酰胺一起施用时,我们证明微生物组通过具有更好的肠道代谢而得到保存。
{"title":"3L, Three-Lactobacilli on Recovering of Microbiome and Immune-Damage by Cyclophosphamide Chemotherapy—A Pilot Experiment in Rats—","authors":"Shousong Yue, Zhenzhong Zhang, F. Bian, Yan Zhang, Gao Chen, Youfeng Zhu, Jun Li, J. Picimbon","doi":"10.3390/microbiolres14030059","DOIUrl":"https://doi.org/10.3390/microbiolres14030059","url":null,"abstract":"We deal with various strains of Lactobacillus that can maintain the intestinal microbiome of rats treated with cyclophosphamide, an anticancer agent (chemotherapy). We use MiSeq and various types of statistical tests to prove that cyclophosphamide in rats alters the intestinal microbiome, favoring the growth of various fungi that are extremely harmful to intestinal metabolism. On the contrary, when Lactobacillus 3L is administered together with cyclophosphamide, we prove that the microbiome is preserved by having a much better intestinal metabolism.","PeriodicalId":43788,"journal":{"name":"Microbiology Research","volume":"46 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87464082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Assessment of Antimicrobial Efficacy of Seven Surface Disinfectants against Eight Bacterial Strains in Saudi Arabia: An In Vitro Study 7种表面消毒剂对沙特阿拉伯8种细菌抗菌效果的比较研究
IF 1.5 Q3 MICROBIOLOGY Pub Date : 2023-06-29 DOI: 10.3390/microbiolres14030058
Naif A. Jalal, Rozan A. Al-Atyyani, Hamdi M. Al-Said, Sami S. Ashgar, H. Faidah, A. Johargy, A. Momenah, A. Barhameen, S. Hariri, Farkad Bantun, Fadi S I Qashqari, E. B. Khidir, Mohammed H. Althagafi
Environmental conditions in hospitals facilitate the growth and spread of pathogenic bacteria on surfaces such as floors, bed rails, air ventilation units, and mobile elements. These pathogens may be eliminated with proper disinfecting processes, including the use of appropriate surface disinfectants. In this study, we aimed to evaluate of the antibacterial effects of seven surface disinfectants (HAMAYA, DAC, AJAX, Jif, Mr. MUSCLE, CLOROX, and BACTIL) against eight bacterial strains Klebsiella pneumoniae, Enterobacter aerogenes, Acinetobacter baumannii, Serratia marcescens, Escherichia coli, vancomycin-resistant Enterococcus faecalis-ATCC 51299, methicillin-resistant Staphylococcus aureus-ATCC 43300, and Pseudomonas aeruginosa-ATCC 1544, using two methods. The first was to determine the effective contact time of disinfectant against the tested bacterial strains, and the second was an assessment of the disinfection efficacy of each disinfectant on six types of contaminated surfaces with on a mixture of the eight tested bacterial strains. The results showed the efficacy of the disinfectants against the tested strains depending on the effective contact time. BACTIL disinfectant showed an efficacy of 100% against all tested strains at the end of the first minute of contact time. HAMAYA, DAC, Jif, Mr. MUSCLE, and CLOROX showed 100% efficiency at the end of the fourth, fifth, sixth, seventh, and fourteenth minutes, respectively, while AJAX disinfectant required nineteen minutes of contact time to show 100% efficacy against all tested strains.
医院的环境条件有利于病原菌在地板、床轨、通风装置和移动元件等表面的生长和传播。这些病原体可以通过适当的消毒程序消除,包括使用适当的表面消毒剂。本研究旨在通过两种方法评价7种表面消毒剂(HAMAYA、DAC、AJAX、Jif、MUSCLE先生、CLOROX和BACTIL)对肺炎克雷伯菌、产气肠杆菌、鲍曼不动杆菌、粘质沙雷菌、大肠杆菌、耐万古霉素的粪肠球菌- atcc 51299、耐甲氧西林的金黄色葡萄球菌- atcc 43300和铜绿假单胞菌- atcc 1544的抑菌效果。第一个是确定消毒剂对测试菌株的有效接触时间,第二个是评估每种消毒剂对六种污染表面与八种测试菌株的混合物的消毒效果。结果表明,消毒剂对受试菌株的效果与有效接触时间有关。在接触第一分钟结束时,BACTIL消毒剂对所有受试菌株的有效性为100%。HAMAYA、DAC、Jif、Mr. MUSCLE和CLOROX分别在第4、第5、第6、第7和第14分钟时显示100%的有效性,而AJAX消毒剂需要19分钟的接触时间才能对所有测试菌株显示100%的有效性。
{"title":"Comparative Assessment of Antimicrobial Efficacy of Seven Surface Disinfectants against Eight Bacterial Strains in Saudi Arabia: An In Vitro Study","authors":"Naif A. Jalal, Rozan A. Al-Atyyani, Hamdi M. Al-Said, Sami S. Ashgar, H. Faidah, A. Johargy, A. Momenah, A. Barhameen, S. Hariri, Farkad Bantun, Fadi S I Qashqari, E. B. Khidir, Mohammed H. Althagafi","doi":"10.3390/microbiolres14030058","DOIUrl":"https://doi.org/10.3390/microbiolres14030058","url":null,"abstract":"Environmental conditions in hospitals facilitate the growth and spread of pathogenic bacteria on surfaces such as floors, bed rails, air ventilation units, and mobile elements. These pathogens may be eliminated with proper disinfecting processes, including the use of appropriate surface disinfectants. In this study, we aimed to evaluate of the antibacterial effects of seven surface disinfectants (HAMAYA, DAC, AJAX, Jif, Mr. MUSCLE, CLOROX, and BACTIL) against eight bacterial strains Klebsiella pneumoniae, Enterobacter aerogenes, Acinetobacter baumannii, Serratia marcescens, Escherichia coli, vancomycin-resistant Enterococcus faecalis-ATCC 51299, methicillin-resistant Staphylococcus aureus-ATCC 43300, and Pseudomonas aeruginosa-ATCC 1544, using two methods. The first was to determine the effective contact time of disinfectant against the tested bacterial strains, and the second was an assessment of the disinfection efficacy of each disinfectant on six types of contaminated surfaces with on a mixture of the eight tested bacterial strains. The results showed the efficacy of the disinfectants against the tested strains depending on the effective contact time. BACTIL disinfectant showed an efficacy of 100% against all tested strains at the end of the first minute of contact time. HAMAYA, DAC, Jif, Mr. MUSCLE, and CLOROX showed 100% efficiency at the end of the fourth, fifth, sixth, seventh, and fourteenth minutes, respectively, while AJAX disinfectant required nineteen minutes of contact time to show 100% efficacy against all tested strains.","PeriodicalId":43788,"journal":{"name":"Microbiology Research","volume":"11 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73637060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Antibody Persistence up to 6 Months after Additional Booster Vaccination with ChAdOx1 nCoV-19 Vaccine 加强接种ChAdOx1 nCoV-19疫苗后抗体持续时间长达6个月的比较
Q3 MICROBIOLOGY Pub Date : 2023-06-16 DOI: 10.3390/microbiolres14020057
Pawita Suwanwattana, May Han, Tanawin Nopsopon, Phanupong Phutrakool, Chatpol Samuthpongtorn, Wannarat Pongpirul, Wisit Prasithsirikul, Krit Pongpirul
Vaccines are crucial for controlling the COVID-19 pandemic, and booster doses are becoming increasingly important. This study aimed to assess the efficacy of the ChAdOx1 nCoV-19 vaccine from AstraZeneca as a third dose in healthcare workers at different time intervals (one, three, and six months). Two methods to measure immune response—ELISA (EUROIMMUN Medizinische Labordiagnostika AG, Luebeck, Germany) and ELISpot (Mabtech AB, Macka Strand, Sweden)—were used. A total of 170 participants were included in the study. The results showed that while IgG levels decreased at six months compared to levels at one and three months, they were still significantly higher than the baseline. Furthermore, neutralizing levels at three and six months and after the third dose were not significantly different. These findings suggest that the immune response induced by the vaccine was robust and effective for several months. These results have significant implications for public health policymakers, as they provide strong support for booster vaccinations. The ChAdOx1 nCoV-19 vaccine appears to be a reliable option for preventing the spread of COVID-19, and this study provides valuable information for healthcare workers and policymakers in managing the pandemic.
疫苗对于控制COVID-19大流行至关重要,加强剂量正变得越来越重要。本研究旨在评估阿斯利康公司的ChAdOx1 nCoV-19疫苗在不同时间间隔(1个月、3个月和6个月)作为医护人员第三剂的疗效。检测免疫反应的两种方法分别是elisa(德国Luebeck的EUROIMMUN Medizinische Labordiagnostika AG)和ELISpot(瑞典Mabtech AB, Macka Strand)。共有170名参与者参与了这项研究。结果显示,虽然与1个月和3个月的水平相比,6个月时IgG水平有所下降,但仍明显高于基线水平。此外,在第3、6个月和第三次剂量后的中和水平没有显著差异。这些结果表明,疫苗诱导的免疫反应在几个月内是稳健有效的。这些结果对公共卫生政策制定者具有重要意义,因为它们为加强疫苗接种提供了强有力的支持。ChAdOx1 nCoV-19疫苗似乎是预防COVID-19传播的可靠选择,本研究为卫生保健工作者和政策制定者管理大流行提供了有价值的信息。
{"title":"Comparison of Antibody Persistence up to 6 Months after Additional Booster Vaccination with ChAdOx1 nCoV-19 Vaccine","authors":"Pawita Suwanwattana, May Han, Tanawin Nopsopon, Phanupong Phutrakool, Chatpol Samuthpongtorn, Wannarat Pongpirul, Wisit Prasithsirikul, Krit Pongpirul","doi":"10.3390/microbiolres14020057","DOIUrl":"https://doi.org/10.3390/microbiolres14020057","url":null,"abstract":"Vaccines are crucial for controlling the COVID-19 pandemic, and booster doses are becoming increasingly important. This study aimed to assess the efficacy of the ChAdOx1 nCoV-19 vaccine from AstraZeneca as a third dose in healthcare workers at different time intervals (one, three, and six months). Two methods to measure immune response—ELISA (EUROIMMUN Medizinische Labordiagnostika AG, Luebeck, Germany) and ELISpot (Mabtech AB, Macka Strand, Sweden)—were used. A total of 170 participants were included in the study. The results showed that while IgG levels decreased at six months compared to levels at one and three months, they were still significantly higher than the baseline. Furthermore, neutralizing levels at three and six months and after the third dose were not significantly different. These findings suggest that the immune response induced by the vaccine was robust and effective for several months. These results have significant implications for public health policymakers, as they provide strong support for booster vaccinations. The ChAdOx1 nCoV-19 vaccine appears to be a reliable option for preventing the spread of COVID-19, and this study provides valuable information for healthcare workers and policymakers in managing the pandemic.","PeriodicalId":43788,"journal":{"name":"Microbiology Research","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135621262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Antibody Persistence up to 6 Months after Additional Booster Vaccination with ChAdOx1 nCoV-19 Vaccine 加强接种ChAdOx1 nCoV-19疫苗后抗体持续时间长达6个月的比较
IF 1.5 Q3 MICROBIOLOGY Pub Date : 2023-06-16 DOI: 10.20944/preprints202304.0364.v1
Pawita Suwanwattana, M. Han, T. Nopsopon, P. Phutrakool, C. Samuthpongtorn, W. Pongpirul, W. Prasithsirikul, K. Pongpirul
Vaccines are crucial for controlling the COVID-19 pandemic, and booster doses are becoming increasingly important. This study aimed to assess the efficacy of the ChAdOx1 nCoV-19 vaccine from AstraZeneca as a third dose in healthcare workers at different time intervals (one, three, and six months). Two methods to measure immune response—ELISA (EUROIMMUN Medizinische Labordiagnostika AG, Luebeck, Germany) and ELISpot (Mabtech AB, Macka Strand, Sweden)—were used. A total of 170 participants were included in the study. The results showed that while IgG levels decreased at six months compared to levels at one and three months, they were still significantly higher than the baseline. Furthermore, neutralizing levels at three and six months and after the third dose were not significantly different. These findings suggest that the immune response induced by the vaccine was robust and effective for several months. These results have significant implications for public health policymakers, as they provide strong support for booster vaccinations. The ChAdOx1 nCoV-19 vaccine appears to be a reliable option for preventing the spread of COVID-19, and this study provides valuable information for healthcare workers and policymakers in managing the pandemic.
疫苗对于控制COVID-19大流行至关重要,加强剂量正变得越来越重要。本研究旨在评估阿斯利康公司的ChAdOx1 nCoV-19疫苗在不同时间间隔(1个月、3个月和6个月)作为医护人员第三剂的疗效。检测免疫反应的两种方法分别是elisa(德国Luebeck的EUROIMMUN Medizinische Labordiagnostika AG)和ELISpot(瑞典Mabtech AB, Macka Strand)。共有170名参与者参与了这项研究。结果显示,虽然与1个月和3个月的水平相比,6个月时IgG水平有所下降,但仍明显高于基线水平。此外,在第3、6个月和第三次剂量后的中和水平没有显著差异。这些结果表明,疫苗诱导的免疫反应在几个月内是稳健有效的。这些结果对公共卫生政策制定者具有重要意义,因为它们为加强疫苗接种提供了强有力的支持。ChAdOx1 nCoV-19疫苗似乎是预防COVID-19传播的可靠选择,本研究为卫生保健工作者和政策制定者管理大流行提供了有价值的信息。
{"title":"Comparison of Antibody Persistence up to 6 Months after Additional Booster Vaccination with ChAdOx1 nCoV-19 Vaccine","authors":"Pawita Suwanwattana, M. Han, T. Nopsopon, P. Phutrakool, C. Samuthpongtorn, W. Pongpirul, W. Prasithsirikul, K. Pongpirul","doi":"10.20944/preprints202304.0364.v1","DOIUrl":"https://doi.org/10.20944/preprints202304.0364.v1","url":null,"abstract":"Vaccines are crucial for controlling the COVID-19 pandemic, and booster doses are becoming increasingly important. This study aimed to assess the efficacy of the ChAdOx1 nCoV-19 vaccine from AstraZeneca as a third dose in healthcare workers at different time intervals (one, three, and six months). Two methods to measure immune response—ELISA (EUROIMMUN Medizinische Labordiagnostika AG, Luebeck, Germany) and ELISpot (Mabtech AB, Macka Strand, Sweden)—were used. A total of 170 participants were included in the study. The results showed that while IgG levels decreased at six months compared to levels at one and three months, they were still significantly higher than the baseline. Furthermore, neutralizing levels at three and six months and after the third dose were not significantly different. These findings suggest that the immune response induced by the vaccine was robust and effective for several months. These results have significant implications for public health policymakers, as they provide strong support for booster vaccinations. The ChAdOx1 nCoV-19 vaccine appears to be a reliable option for preventing the spread of COVID-19, and this study provides valuable information for healthcare workers and policymakers in managing the pandemic.","PeriodicalId":43788,"journal":{"name":"Microbiology Research","volume":"33 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91332378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Microbiology Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1